PsyBio Therapeutics BPA
Quel est le BPA de PsyBio Therapeutics?
Le BPA de PsyBio Therapeutics Corp. est -0.12
Quelle est la définition de BPA?
Le bénéfice par action (BPA) est la partie du bénéfice d’une société affectée à chaque action en circulation d’actions ordinaires. Il est ajusté pour tenir compte de la dilution et calculé sur douze mois.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
BPA des entreprises dans Health Care secteur sur TSXV par rapport à PsyBio Therapeutics
Que fait PsyBio Therapeutics?
PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. The company is headquartered in Coconut Creek, Florida.
Entreprises avec bpa similaire à PsyBio Therapeutics
- Trident Acquisitions a BPA de -0.12
- Vatic Ventures a BPA de -0.12
- Tonies Se Eo 1 a BPA de -0.12
- BASE a BPA de -0.12
- Hidili Industry International Development a BPA de -0.12
- Punjab National Bank a BPA de -0.12
- PsyBio Therapeutics a BPA de -0.12
- Cyclopharm a BPA de -0.11
- Medcolcanna Organics a BPA de -0.11
- Intrasense SA a BPA de -0.11
- Asia Cassava Resources a BPA de -0.11
- Heliostar Metals a BPA de -0.11
- Largo Resources a BPA de -0.11